Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 10,868 shares at $17.90 ($195K) on 2024-03-27, disclosed to the SEC on 2024-03-27.
Open-market sale of $195k ACAD by EVP, CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.90 | 5,434 | $97K | 50.0% |
| 2 | $17.90 | 5,434 | $97K | 50.0% |
| Total | $17.90 avg | 10,868 | $195K | 100% |
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |